Revised forecast
Fiscal year ending September 2026 · Full yearPrevious forecast published 11 November 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
In the Life Platform business, amid favorable sales conditions, selling prices for projects sold during the current fiscal year significantly exceeded the initial forecast, improving the gross profit margin. In light of the higher selling prices, the sales timing for certain projects is also being strategically changed to the following fiscal year.
| Item | Details |
|---|---|
| Net Sales | 100,450 Millions of yen → 101,900 Millions of yen（+1.4%） |
| Operating profit | 11,000 Millions of yen → 13,650 Millions of yen（+24.1%） |
| Ordinary income | 9,300 Millions of yen → 11,650 Millions of yen（+25.3%） |
| Profit attributable to owners of the parent | 5,800 Millions of yen → 7,550 Millions of yen（+30.2%） |
| Net income per share | 94.03 yen and sen → 122.4 yen and sen |
| Fiscal Period Covered | Fiscal year ending September 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 11 November 2025 |
| Previous-period results | Fiscal year ended September 2025: revenue of ¥74,412 million, EBITDA of ¥9,102 million, operating profit of ¥8,815 million, ordinary profit of ¥7,808 million, net income attributable to owners of the parent of ¥4,933 million, and net income per share of ¥90.99 |
| Reason for the revision | In the Life Platform business, amid favorable sales conditions, selling prices for projects sold during the current fiscal year significantly exceeded the initial forecast, improving the gross profit margin. In light of the higher selling prices, the sales timing for certain projects is also being strategically changed to the following fiscal year. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the Life Platform business, amid favorable sales conditions, selling prices for projects sold during the current fiscal year significantly exceeded the initial forecast, improving the gross profit margin. In light of the higher selling prices, the sales timing for certain projects is being strategically changed to the following fiscal year.